Case Report: Renal Cell Carcinoma, Male, Aged 63

  • Post comments:0 Comments
📄 6 mins.
Image about a Renal Cell Carcinoma. A 63-year-old male cured it by using fenbendazole. This is an image for a case report about that.

This case study is about a 63-year-old man who has metastatic kidney cancer that has spread to other important organs like his pancreas, lungs, and bones. He first tried immunotherapy, but unfortunately, it didn’t work. Traditional chemotherapy was ineffective, and no other treatments were used.

He was then given only about 6 months to live when he learned about a potential option called Fenbendazole. He started a regime of taking 222 mg for 3 days in a row and then took 4 days off.

Within 2 months, the largest kidney tumor was gone, and the smaller ones had shrunk a lot. By 5 months, all signs of tumors had vanished. Doctors later shared his case in a medical journal. This offers hope that Fenbendazole may help others facing similar health challenges.

The Patient’s Journey Through Stage 4 Kidney Cancer

I faced major health issues as my stage 4 kidney cancer spread widely. The cancer impacted multiple important organs, like my inferior vena cava (IVC), heart, lungs, pancreas, hip, and spine.

April 2019

In April 2019, doctors determined my condition was very serious, giving me around 6 months to live. As a last attempt, I received immunotherapy treatment combining two medicines (Cabozantinib and Nivolumab).

I was given 3 half doses, and though it was intended to help, it caused problems like a rash and stomach inflammation.

August 2019

Due to these side effects, the treatment had to end prematurely. Later in August 2019, I started taking the medication Fenbendazole (222 mg) with no added vitamins or CBD. I did this hoping it could offer improvement without the addition of other supplements.

October 2019

In October 2019, I received encouraging results from MRI scans at Stanford. Surprisingly, the largest tumor in my kidney had vanished! The other tumors had also reduced significantly in size.

January 2020

Further scans at Stanford in January 2020 brought wonderful news; no cancer could be detected anywhere in my body.

It’s incredible to think the disease is now in full remission. I’ve continued taking the medication Fenbendazole on a regular schedule without other supplements. My medical records document this remarkable outcome. While vitamins and other substances may help, it seems this treatment alone can destroy cancer cells effectively. I’m living proof of its potential.

Remarkable Recovery: Fenbendazole’s Impact on Metastatic Renal Cell Carcinoma

The medical team at Stanford was so impressed by the recovery that they wrote a case study for publication.

The medical team at Stanford was so impressed by the recovery that they wrote a case study for publication (Source.). Case 1 features the story of a 63-year-old male diagnosed with Renal Cell Carcinoma that had extensively metastasized. This was shared in September 2021 and brings much attention to Fenbendazole’s potential benefits.

To this day, he continues taking the prescribed amount of Fenbendazole on a rotating schedule without any difficulties. Research shows this medication can be used regularly long-term as it is perfectly safe.

He hopes that sharing his encouraging experience gives readers hope and guidance if they are facing serious health issues. Good luck, and God Bless.

Journey of a 63-Year-Old Male with Renal Cell Carcinoma

A 63-year-old man came to his doctor with concerns about pain in his side, unintentional weight loss, and a brief fever episode. A CT test was done, which detected a solid lower pole renal mass in his left kidney measuring about 3 centimeters.

A partial nephrectomy was performed to safely remove part of the kidney, and an examination of the tissue found it to be a high-grade clear cell Renal Cell Carcinoma (RCC). Several months later, he returned with continued pain in his side. Further evaluation uncovered a 5.2-centimeter mass in the same kidney.

A minimally invasive biopsy confirmed it was the same cancer type. He then began treatment with a prescription medication called Pazopanib. Follow-up scans showed a new small growth in the pancreas area as well as a lingering kidney mass.

There were also indications of inflammation in the sigmoid colon. Due to worries about the disease progressing and side effects that were hard to tolerate, Pazopanib was stopped. A different prescription, called Cabozantinib, was then started.

New scans showed the returning kidney growth was stable in size, the pancreatic head lesion was slightly smaller, and a small lesion was found in the right pelvic bone. However, intolerable side effects from the new medication continued, so treatment with Cabozantinib also had to be discontinued.

One Month Later: Progress and Setbacks in Cancer Treatment

Image is a symbolick illustration of Progress and Setbacks in Cancer Treatment using fenbendazole. Not every time everything goes smooth.

About one month later, follow-up MRI scans showed some concerning changes. The returning kidney mass had enlarged further. However, the pancreatic head growth was slightly smaller, which was encouraging. The lesions in the pancreas body and pelvic bone remained stable in size.

A third treatment was started called Nivolumab, but unfortunately, after only three doses over one month, it had to be stopped. This was because the patient developed a severe rash and colon inflammation. Steroid medication was able to resolve the colon issue.

During this challenging period, the patient’s friend with a different cancer type suggested trying an alternative approach using Fenbendazole. So in addition to medical care, he began taking that supplement on a rotating weekly schedule.

6 Months Later: Significant Improvements and Continued Success

Follow-up MRI scans revealed very promising changes. The mass in the left kidney had nearly disappeared. Also, the spots in the pancreas and pelvic bone regions had all reduced in size significantly. Medical imaging over the past ten months has not detected any return of cancer cells or signs of spread elsewhere in the body.

The patient has continued taking Fenbendazole on the previous routine without any side effects.

Exploring Fenbendazole’s Efficacy and Safety in Cancer Treatment

The image represents diferent products and different forms of fenbendazole whitch can be in powder, liquid, paste, capsule or tablet form.

This case underscores some meaningful insights. Notably, it appears Fenbendazole on its own achieved excellent outcomes, as no additional vitamins or therapies seemed needed. Although the treatment showed positive interactions with previous immunotherapies, its continued success as a standalone supplement suggests that it may enhance the effectiveness of other treatments. Also remarkable is the lack of negative side effects experienced throughout.

Leave a Reply